ManuPharma 2020

01 - 02 December, 2020

Radisson Blu Berlin, Germany

Contact Us: 44 (0) 207 036 1363

Whitepaper & Report Center

[On-Demand Webinar] Why Digitalization is the Key to Transforming Development and Manufacturing in Pharma

The competition to provide consistent quality and efficiency in your manufacturing processes is fierce. Manufacturers must ensure that therapies are consistently produced ‘as designed’ and ‘as registered’ whilst at the same time being more flexible and modular. The challenges surrounding this, and the continuing development and increasing popularity of advanced biologic medicines, have created a paradigm shift for pharmaceutical manufacturers.


Restructuring Pharma Manufacturing Around Innovation

In Q3 of 2019 WBR Insights surveyed 100 VPs of Manufacturing Operations, VPs of Technical Operations, and roles of a similar standing from across Europe to find out more about the challenges they’re facing and the innovative solutions being brought to the table. The survey was conducted by appointment over the telephone. The results were compiled and anonymised by WBR Insights and are presented here with analysis and commentary by the ManuPharma community.


Digitizing the entire validation life cycle: A productivity leap

A US headquartered tier one biotech, with multiple facilities in the US and the EU, achieved validation productivity improvements of 100% after digitizing validation on the Kneat paperless validation platform. The client introduces many new therapies every year, and with the addition of a new facility, the number of paper-based validation protocols required was forecast to grow rapidly from an already high average of 700 per year.  Increasing regulatory expectations were also contributing to the validation challenge. 


Revolution Vs Regulation: the 2018 ManuPharma Report

In Q3 of 2018 WBR Insights surveyed 100 VPs of Manufacturing Operations, VPs of Technical Operations, and roles of a similar standing from across Europe to find out more about the challenges they’re facing and the innovative solutions being brought to the table. The survey was conducted by appointment over the telephone. The results were compiled and anonymised by WBR Insights and are presented here with analysis and commentary by the ManuPharma community.



Want even more reading material? View whitepapers and reports from our 2019 event.

2019 Media Center